# ObvioHealth

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/obviohealth

- Industry: Healthcare IT
- Headquarters: New York, US
- Website: www.obviohealth.com
- Total disclosed funding: $19M
- Latest round: Series B (Mar 10, 2021)
- Investors on record: 3

## About

Based in New York, US, and founded in 2017, ObvioHealth operates as a digital health company. The company was founded by its CEO Ivan Jarry. In July 2021, ObvioHealth raised USD 31 million in series B funding, led by investors Dedalus Group and Novotech Health Holdings Pte. Ltd.

The company’s product line includes a virtual clinical trial platform and a BYOD (bring your own device) app, which is a mobile application that allows patients to complete (electronic patient-reported outcomes) ePRO in clinical trials. In addition, the company offers a wide range of services such as digital recruitment services, remote patient monitoring, data analysis, visualization, and reporting.

The company plans to use the funds raised in July 2021 to expand the IT capabilities of its ecosystem and plans to increase its hiring.

## Funding rounds

- Series B, Mar 10, 2021, $19M — Tikehau Capital, IQVIA, Inc., Sprim Ventures

## Investors

- Tikehau Capital — Series B
- IQVIA, Inc. — Series B
- Sprim Ventures (https://capitalatlas.ai/funds/sprim-ventures) — Series B